Market closedNon-fractional

Achieve Life Sciences/ACHV

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Achieve Life Sciences

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Ticker

ACHV

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Vancouver, Canada

Employees

22

ACHV Metrics

BasicAdvanced
$159M
Market cap
-
P/E ratio
-$1.26
EPS
1.26
Beta
-
Dividend rate
$159M
1.26
3.291
3.227
34.766
-7.97%
-33.93%
-109.49%
3.24
3.39
-4.657
-63.32%
-36.86%

What the Analysts think about ACHV

Analyst Ratings

Majority rating from 7 analysts.
Buy

ACHV Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$6.4M
18.52%
Profit margin
0.00%
NaN%

ACHV Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 6.56%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.43
-$0.34
-$0.26
-$0.26
-
Expected
-$0.42
-$0.38
-$0.31
-$0.24
-$0.23
Surprise
2.03%
-10.19%
-17.27%
6.56%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Achieve Life Sciences stock?

Achieve Life Sciences (ACHV) has a market cap of $159M as of July 23, 2024.

What is the P/E ratio for Achieve Life Sciences stock?

The price to earnings (P/E) ratio for Achieve Life Sciences (ACHV) stock is 0 as of July 23, 2024.

Does Achieve Life Sciences stock pay dividends?

No, Achieve Life Sciences (ACHV) stock does not pay dividends to its shareholders as of July 23, 2024.

When is the next Achieve Life Sciences dividend payment date?

Achieve Life Sciences (ACHV) stock does not pay dividends to its shareholders.

What is the beta indicator for Achieve Life Sciences?

Achieve Life Sciences (ACHV) has a beta rating of 1.26. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Achieve Life Sciences stock

Buy or sell Achieve Life Sciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing